| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |